In addition, this study showed that clopidogrel alleviated hepatic steatosis, probably through restraining CD36-mediated fatty acid uptake, consistent with a previous finding that clopidogrel downregulates the expression of CD36 (Mokgalaboni et al., 2020). The gene discussed is CD36; the disease is fatty liver disease.